TY  - JOUR 
AU  - Fernández-Díaz, Cristina M.
AU  - Merino, Beatriz
AU  - López-Acosta, José F.
AU  - Cidad, Pilar
AU  - de la Fuente, Miguel A.
AU  - Lobatón, Carmen D.
AU  - Moreno, Alfredo
AU  - Leissring, Malcolm A.
AU  - Perdomo, Germán
AU  - Cózar-Castellano, Irene
PY  - 2019
SN  - 0193-1849
UR  - https://uvadoc.uva.es/handle/10324/74563
AB  - Inhibition of insulin-degrading enzyme (IDE) has been proposed as a possible therapeutic target for type 2 diabetes treatment. However, many aspects of IDE's role in glucose homeostasis need to be clarified. In light of this, new preclinical models...
LA  - spa
TI  - Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity
DO  - 10.1152/ajpendo.00040.2019
ER  -